Friday, March 4, 2005
8:00 am - 12:10 pm Session I: Surgery/Radiation/DCIS
Moderator: Olufunmilayo Olopade

1. Micrometastatic Disease and the Sentinel Node: Emerging Data - Ronald Jones
2. Limited Field Radiation: Ready for Prime Time? - Lori Pierce
3. Using MRI as a Screening Tool - Steve Harms
4. Point / Counterpoint: Is AC Dead? - Peter Ravdin and Hyman Muss
5. New Tools in the Diagnosis and Treatment DCIS - William Dooley
6. Hormone Use and Misuse: Lessons from the Women’s Health Initiative - Rowan Chlebowski
7. Gene Expression Profiles in Predicting Response - Lajos Pusztai
8. Assessing Adjuvant Benefit - Peter Ravdin
9. Case Presentation: New Data from the NSABP Eleftherios Mamounas

Saturday, March 5, 2005
8:00 am - 1:00 pm Session II: Adjuvant Chemotherapy and Hormonal Therapy/Predicting Response
Moderator: Hyman Muss

1. Role of Host and Tumor Genetics Olufunmilayo in Breast Cancer Management..... - Olopade
2. Hormonal Agents in the Neo-adjuvant Setting - Matthew Ellis
3. Dose Dense Therapy: Still First Choice? - Clifford Hudis
4. Case Presentation: Adjuvant Endocrine Therapy - Hyman Muss
5. Update on Anthracyclines - Stefan Glück
6. Update on Fluoropyrimidines - Joanne Blum
7. Panel Discussion and Case-Based Workshop

Sunday, March 6, 2005
8:00am - 1:00 pm Session II: Adjuvant Chemotherapy and Hormonal Therapy/Predicting Response
Moderator: Nicholas Robert

1. Managing Skeletal Metastases - Charles Vogel
2. Anti-emetics: Are there new standards? - Steven Grunberg
3. Managing Hot Flashes and Other Common Symptoms - Charles Loprinzi
4. Case Presentation: Taxanes in the Adjuvant Setting - Edith Perez
5. Update on Targeted Therapies for Breast Cancer. - Mark Pegram
6. Update on Taxanes - Joanne Blum
7. New Strategies for Metastatic Breast Cancer - Howard Burris
8. Case Presentation: Metastatic Disease - Nicholas Robert